$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019
[Published by MarketsandMarkets]

Published by MarketsandMarkets: 05 Mar 2015 | 41366 | In Stock

Introduction

Over the years, the hemodynamic monitoring systems market has witnessed various technological advancements in order to better serve the critically ill patients. These advancements have led to the development of minimally invasive and noninvasive hemodynamic monitoring systems with an aim to reduce pain, increase comfort, and most importantly reduce infectious diseases, primarily sepsis.

In 2014, the disposables segment accounted for the largest share of the global hemodynamic monitoring systems market, by product; the invasive hemodynamic monitoring systems segment accounted for the largest share of the hemodynamic monitoring systems market, by type; while the hospitals segment accounted for a major share of the hemodynamic monitoring system market, by end user.

In 2014, North America accounted for the largest share of the global hemodynamic monitoring systems market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the hemodynamic monitoring systems market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of hemodynamic monitoring systems.

The global hemodynamic monitoring systems market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hemodynamic monitoring systems market. The report analyzes hemodynamic monitoring systems by product, by type, and by end-user

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the hemodynamic monitoring systems market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring system technologies across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the hemodynamic monitoring systems market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the hemodynamic monitoring systems market

Table of Contents
for Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 [Published by MarketsandMarkets]

  • TABLE OF CONTENTS

    1 INTRODUCTION 18

    1.1 OBJECTIVES OF THE STUDY 18

    1.2 MARKET DEFINITION 18

    1.3 MARKET SCOPE 19

    1.3.1 MARKETS COVERED 19

    1.3.2 YEARS CONSIDERED FOR THE STUDY 20

    1.4 CURRENCY & PRICING 20

    1.5 LIMITATIONS 20

    1.6 STAKEHOLDERS 20

    2 RESEARCH METHODOLOGY 21

    2.1 RESEARCH DATA 21

    2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 22

    2.2.1 SECONDARY RESEARCH 22

    2.2.1.1 Key data from secondary sources 22

    2.2.2 PRIMARY RESEARCH 23

    2.2.2.1 Key Industry Insights 24

    2.2.2.2 Break Down of Primary Interviews: by Company Type, Designation, and Region 25

    2.2.2.3 Key data from primary sources 25

    2.2.2.4 Key Insights from primary sources 26

    2.3 MARKET SIZE ESTIMATION 26

    2.3.1 MARKET FORECAST METHODOLOGY 29

    2.3.2 MARKET DATA VALIDATION AND TRIANGULATION 29

    2.4 ASSUMPTIONS 30

    3 EXECUTIVE SUMMARY 31

    3.1 INTRODUCTION 31

    3.2 CURRENT SCENARIO 32

    3.3 FUTURE OUTLOOK 33

    3.4 CONCLUSION 34

    4 PREMIUM INSIGHTS 35

    4.1 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET 35

    4.2 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION AND TYPE 36

    4.3 REGIONAL SNAPSHOT OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET 37

    4.4 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2014 VS. 2019) 37

    5 MARKET OVERVIEW 38

    5.1 INTRODUCTION 39

    5.2 MARKET SEGMENTATION 39

    5.3 MARKET DYNAMICS 40

    5.3.1 DRIVERS 40

    5.3.1.1 Technological advancements in hemodynamic monitoring systems 40

    5.3.1.1.1 Noninvasive hemodynamic monitoring systems 41

    5.3.1.1.2 Micro-Electro-Mechanical Systems (MEMS) technology 41

    5.3.1.2 Growth in the number of people suffering from hypertension 41

    5.3.1.3 Growing diabetic population 41

    5.3.1.4 Rapid growth in aging population 43

    5.3.2 RESTRAINTS 44

    5.3.2.1 Risks associated with invasive hemodynamic monitoring 44

    5.3.3 OPPORTUNITIES 45

    5.3.3.1 India and China to provide significant growth opportunities for the hemodynamic monitoring systems market 45

    6 INDUSTRY TRENDS 46

    6.1 PORTER’S FIVE FORCES ANALYSIS 46

    6.1.1 SUPPLIER’S BARGAINING POWER 46

    6.1.1.1 Presence of a large number of suppliers 47

    6.1.1.2 Low dependency on single supplier 47

    6.1.1.3 Dependency on type of technology 47

    6.1.2 BUYER’S BARGAINING POWER 47

    6.1.2.1 Large supplier pool 47

    6.1.3 THREAT OF NEW ENTRANTS 47

    6.1.3.1 Capital-intensive market 47

    6.1.3.2 Stronghold of existing players 47

    6.1.3.3 Reimbursement coverage 47

    6.1.4 THREAT OF SUBSTITUTES 48

    6.1.4.1 Lack of alternatives 48

    6.1.5 INTENSITY OF COMPETITIVE RIVALRY 48

    6.1.5.1 Presence of a large number of small firms 48

    6.2 SUPPLY CHAIN ANALYSIS 48

    6.2.1 PROMINENT COMPANIES 49

    6.2.2 SMALL AND MEDIUM ENTERPRISES 49

    6.2.3 END USERS (PATIENTS/HOSPITALS/LABS/CLINICS) 49

    6.2.4 KEY INFLUENCERS 50

    7 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT 51

    7.1 INTRODUCTION 52

    7.2 SYSTEMS (MONITORS) 53

    7.2.1 DISPLAY SYSTEMS 53

    7.2.2 UNIFIED HEMODYNAMIC MONITORING SYSTEMS 53

    7.3 DISPOSABLES 56

    7.3.1 BALLOON CATHETERS 56

    7.3.2 MEASUREMENT PROBES 56

    7.3.3 SENSORS 57

    7.3.4 GUIDEWIRES 57

    8 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE 60

    8.1 INTRODUCTION 61

    8.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS 63

    8.2.1 APPLICATIONS OF INVASIVE HEMODYNAMIC MONITORING SYSTEMS 63

    8.2.2 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING 63

    8.2.3 PRODUCTS 64

    8.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS 66

    8.3.1 APPLICATIONS 67

    8.3.2 PRODUCTS 67

    8.4 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS 70

    8.4.1 PRODUCTS 70

    9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER 74

    9.1 INTRODUCTION 75

    9.2 HOSPITALS 77

    9.3 CATHETERIZATION LABORATORIES (CATH LABS) 79

    9.4 HOME AND AMBULATORY SITES 81

    10 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION 84

    10.1 INTRODUCTION 85

    10.2 NORTH AMERICA 86

    10.2.1 U.S. 89

    10.2.1.1 Growing diabetes prevalence to boost the market for hemodynamic monitoring systems 89

    10.2.1.2 Reimbursement offerings by companies to drive the market 89

    10.2.2 CANADA 90

    10.2.2.1 High diabetes prevalence to boost the market for hemodynamic monitoring systems 90

    10.3 EUROPE 92

    10.3.1 GERMANY 94

    10.3.1.1 High Diabetes Prevalence to Accelerate the Market Growth in Germany 94

    10.3.1.2 S3 guidelines for intensive care in cardiac surgeries 94

    10.3.2 U.K. 96

    10.3.2.1 Rising prevalence of diabetes and cardiovascular diseases in the U.K. 96

    10.3.3 REST OF EUROPE (ROE) 97

    10.3.3.1 SFAR guidelines in France have made ODM (Oesophageal Doppler Monitors) a standard of care in the country 97

    10.3.3.2 High diabetes prevalence in Russia, Turkey, Poland, Romania, and Ukraine to propel the market for hemodynamic monitoring systems in these countries 98

    10.4 ASIA 99

    10.4.1 JAPAN 101

    10.4.1.1 Reimbursement offerings by LiDCO Group plc in Japan to propel the market growth 101

    10.4.2 CHINA 103

    10.4.2.1 High diabetes incidence and rapidly aging population to drive the market in China 103

    10.4.3 INDIA 104

    10.4.3.1 Increased demand for critical care units and high diabetes incidence to drive the market in India 104

    10.4.4 REST OF ASIA 106

    10.4.4.1 Adoption of hemodynamic monitoring systems in Vietnam, Singapore, & Malaysia to increase owing to high diabetes prevalence 106

    10.4.4.2 Tensys Medical’s strong marketing strategy to bolster the market for noninvasive hemodynamic monitoring in China and Taiwan 106

    10.5 REST OF THE WORLD (ROW) 108

    10.5.1 LATIN AMERICA 110

    10.5.1.1 High diabetes prevalence in Brazil 110

    10.5.2 MIDDLE EAST AND AFRICA 111

    10.5.2.1 Rise in adoption of hemodynamic monitoring systems in the Middle East & Africa due to high diabetes prevalence 111

    10.5.3 PACIFIC COUNTRIES 112

    10.5.3.1 High diabetes prevalence and rising incidence of CVDs to drive the growth of hemodynamic monitoring systems in Pacific Countries 112

    11 COMPETITIVE LANDSCAPE 115

    11.1 OVERVIEW 115

    11.2 MARKET SHARE ANALYSIS 116

    11.2.1 EDWARDS LIFESCIENCES CORPORATION 116

    11.2.2 PULSION MEDICAL SYSTEMS SE 118

    11.2.3 LIDCO GROUP PLC 118

    11.3 COMPETITIVE SITUATION AND TRENDS 119

    11.3.1 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS 120

    11.3.2 EXPANSIONS 121

    11.3.3 MERGERS AND ACQUISITIONS 122

    11.3.4 NEW PRODUCT LAUNCHES 123

    11.3.5 OTHERS 124

    12 COMPANY PROFILES 125

    12.1 INTRODUCTION 125

    12.2 CHEETAH MEDICAL, INC. 126

    12.3 DELTEX MEDICAL GROUP PLC 128

    12.4 EDWARDS LIFESCIENCES CORPORATION 130

    12.5 HEMO SAPIENS, INC. 133

    12.6 ICU MEDICAL, INC. 134

    12.7 LIDCO GROUP PLC 136

    12.8 OSYPKA MEDICAL GMBH 139

    12.9 PULSION MEDICAL SYSTEMS SE 141

    12.10 SCHWARZER CARDIOTEK GMBH 143

    12.11 TENSYS MEDICAL, INC. 145

    *Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

    13 APPENDIX 147

    13.1 DISCUSSION GUIDE 147

    13.2 COMPANY DEVELOPMENTS (2012–2014) 150

    13.2.1 LIDCO GROUP PLC 150

    13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 151

    13.4 AVAILABLE CUSTOMIZATIONS 151

    13.5 RELATED REPORTS 152

List Of Tables
in Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 [Published by MarketsandMarkets]

LIST OF TABLES


TABLE 1 TOP 10 COUNTRIES/TERRITORIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2013 VS. 2035 42

TABLE 2 GROWTH IN THE NUMBER OF PEOPLE SUFFERING FROM HYPERTENSION DRIVING THE GROWTH OF THE HEMODYNAMICS MONITORING SYSTEMS MARKET 43

TABLE 3 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING ARE RESTRAINING THE GROWTH OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET 44

TABLE 4 INDIA AND CHINA TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE HEMODYNAMIC MONITORING SYSTEMS MARKET 45

TABLE 5 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 52

TABLE 6 HEMODYNAMIC MONITORS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 54

TABLE 7 NORTH AMERICA: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,

2012–2019 ($MILLION) 54

TABLE 8 EUROPE: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,

2012–2019 ($MILLION) 55

TABLE 9 ASIA: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,

2012–2019 ($MILLION) 55

TABLE 10 ROW: HEMODYNAMIC MONITORS MARKET SIZE, BY REGION,

2012–2019 ($MILLION) 55

TABLE 11 HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE, BY REGION,

2012–2019 ($MILLION) 57

TABLE 12 NORTH AMERICA: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION) 58

TABLE 13 EUROPE: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION) 58

TABLE 14 ASIA: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION) 59

TABLE 15 ROW: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,

BY REGION, 2012–2019 ($MILLION) 59

TABLE 16 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($MILLION) 61

TABLE 17 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 (UNITS) 62

TABLE 18 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,

2012–2019 (UNITS) 63

TABLE 19 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 64

TABLE 20 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 (UNITS) 64

TABLE 21 NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 65

TABLE 22 EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION) 65

TABLE 23 ASIA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY, 2012–2019 ($THOUSAND) 66

TABLE 24 ROW: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY REGION, 2012–2019 ($THOUSAND) 66

TABLE 25 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY REGION, 2012–2019 ($MILLION) 67

TABLE 26 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY REGION, 2012–2019 (UNITS) 68

TABLE 27 NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 68

TABLE 28 EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 69

TABLE 29 ASIA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 69

TABLE 30 ROW: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 70

TABLE 31 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 71

TABLE 32 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 (UNITS) 71

TABLE 33 NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($THOUSAND) 72

TABLE 34 EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY, 2012–2019 ($THOUSAND) 72

TABLE 35 ASIA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY, 2012–2019 ($THOUSAND) 72

TABLE 36 ROW: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY REGION, 2012–2019 ($THOUSAND) 73

TABLE 37 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,

2012–2019 ($MILLION) 75

TABLE 38 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION) 76

TABLE 39 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY COUNTRY/REGION, 2012–2019 ($MILLION) 76

TABLE 40 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 76

TABLE 41 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,

2012–2019 ($MILLION) 77

TABLE 42 HOSPITALS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 78

TABLE 43 NORTH AMERICA: HOSPITALS MARKET SIZE, BY COUNTRY,

2012–2019 ($MILLION) 78

TABLE 44 EUROPE: HOSPITALS MARKET SIZE, BY COUNTRY/REGION,

2012–2019 ($MILLION) 78

TABLE 45 ASIA: HOSPITALS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 79

TABLE 46 ROW: HOSPITALS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 79

TABLE 47 CATH LABS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 80

TABLE 48 NORTH AMERICA: CATH LABS MARKET SIZE, BY COUNTRY,

2012–2019 ($THOUSAND) 80

TABLE 49 EUROPE: CATH LABS MARKET SIZE, BY COUNTRY/REGION,

2012–2019 ($THOUSAND) 80

TABLE 50 ASIA: CATH LABS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 81

TABLE 51 ROW: CATH LABS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 81

TABLE 52 HOME AND AMBULATORY SITES MARKET SIZE, BY REGION,

2012–2019 ($THOUSAND) 82

TABLE 53 NORTH AMERICA: HOME AND AMBULATORY SITES MARKET SIZE,

BY COUNTRY, 2012–2019 ($THOUSAND) 82

TABLE 54 EUROPE: HOME AND AMBULATORY SITES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 82

TABLE 55 ASIA: HOME AND AMBULATORY SITES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 83

TABLE 56 ROW: HOME AND AMBULATORY SITES MARKET SIZE, BY REGION,

2012–2019 ($THOUSAND) 83

TABLE 57 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,

2012–2019 ($MILLION) 85

TABLE 58 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY PRODUCT, 2012–2019 ($MILLION) 87

TABLE 59 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY TYPE, 2012–2019 ($THOUSAND) 88

TABLE 60 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY END USER, 2012–2019 ($THOUSAND) 88

TABLE 61 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 89

TABLE 62 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 90

TABLE 63 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,

2012–2019 ($THOUSAND) 90

TABLE 64 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 91

TABLE 65 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 91

TABLE 66 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 91

TABLE 67 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 93

TABLE 68 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 93

TABLE 69 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 93

TABLE 70 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 94

TABLE 71 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($THOUSAND) 95

TABLE 72 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 95

TABLE 73 AVERAGE PREVALENCE OF DIABETES IN THE U.K. IN ADULTS IS 6.0% (2013) 96

TABLE 74 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 96

TABLE 75 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 97

TABLE 76 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,

2012–2019 ($THOUSAND) 97

TABLE 77 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 98

TABLE 78 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 99

TABLE 79 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 99

TABLE 80 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 100

TABLE 81 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 101

TABLE 82 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 101

TABLE 83 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 102

TABLE 84 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 102

TABLE 85 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 103

TABLE 86 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 103

TABLE 87 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 104

TABLE 88 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 104

TABLE 89 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 105

TABLE 90 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 105

TABLE 91 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 106

TABLE 92 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($MILLION) 107

TABLE 93 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 107

TABLE 94 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,

2012–2019 ($THOUSAND) 107

TABLE 95 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,

2012–2019 ($THOUSAND) 109

TABLE 96 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,

2012–2019 ($THOUSAND) 109

TABLE 97 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 109

TABLE 98 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY PRODUCT, 2012–2019 ($THOUSAND) 110

TABLE 99 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY TYPE, 2012–2019 ($THOUSAND) 110

TABLE 100 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY END USER, 2012–2019 ($THOUSAND) 111

TABLE 101 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($THOUSAND) 111

TABLE 102 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($THOUSAND) 112

TABLE 103 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END-USER, 2012–2019 ($THOUSAND) 112

TABLE 104 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY PRODUCT, 2012–2019 ($THOUSAND) 113

TABLE 105 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY TYPE, 2012–2019 ($THOUSAND) 113

TABLE 106 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,

BY END USER, 2012–2019 ($THOUSAND) 114

TABLE 107 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS,

2012–2014 120

TABLE 108 EXPANSIONS, 2012–2014 121

TABLE 109 MERGERS AND ACQUISITIONS, 2012–2014 122

TABLE 110 NEW PRODUCT LAUNCHES, 2012–2014 123

TABLE 111 OTHER DEVELOPMENTS, 2012–2014 124

List Of Figures, Charts and Diagrams
in Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 [Published by MarketsandMarkets]

LIST OF FIGURES


FIGURE 1 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS 21

FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 24

FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28

FIGURE 5 RESEARCH DESIGN 29

FIGURE 6 DATA TRIANGULATION METHODOLOGY 30

FIGURE 7 MINIMALLY INVASIVE HEMODYNMAIC MONITORING SYSTEMS MARKET TO WITNESS THE HIGHEST CAGR OF 6.0% FROM 2014 TO 2019 31

FIGURE 8 DISPOSABLES SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2014–2019 33

FIGURE 9 HOSPITALS END-USER SEGMENT DOMINATES THE MARKET 33

FIGURE 10 ASIA IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET 34

FIGURE 11 HEMODYNAMIC MONITORING SYSTEMS: MARKET OVERVIEW 35

FIGURE 12 NORTH AMERICA DOMINATED THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2014 36

FIGURE 13 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37

FIGURE 14 INVASIVE HEMODYNAMIC MONITORING SYSTEMS COMMANDED THE LARGEST SHARE 37

FIGURE 15 HEMODYNAMIC MONITORING SYSTEMS: MARKET SEGMENTATION 39

FIGURE 16 HEMODYNAMIC MONITORING SYSTEMS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 40

FIGURE 17 PORTER’S FIVE FORCES ANALYSIS: HEMODYNAMIC MONITORING SYSTEMS MARKET 46

FIGURE 18 SUPPLY CHAIN: DIRECT DISTRIBUTION IS THE MOST PREFERRED STRATEGY FOLLOWED BY PROMINENT PLAYERS 49

FIGURE 19 DISPOSABLES MARKET EXPECTED TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 52

FIGURE 20 INVASIVE HEMODYNAMIC MONITORING SYSTEMS COMMANDED LARGEST MARKET SHARE IN 2014 62

FIGURE 21 HOSPITALS SEGMENT DOMINATED THE HEMODYNAMIC MONITORING SYSTEMS MARKET 75

FIGURE 22 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET 86

FIGURE 23 U.S. TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN NORTH AMERICA 87

FIGURE 24 GERMANY TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN EUROPE 92

FIGURE 25 EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2012 98

FIGURE 26 CHINA IS THE FASTEST-GROWING HEMODYNAMIC MONITORING SYSTEMS MARKET IN ASIA 100

FIGURE 27 ROW ACCOUNTED FOR A SHARE OF 10.5% OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2014 108

FIGURE 28 EXPANSIONS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2011 AND 2014 115

FIGURE 29 MARKET SHARE ANALYSIS OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY KEY PLAYER, 2014 116

FIGURE 30 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS WAS THE KEY STRATEGY 119

FIGURE 31 GEOGRAPHICAL REVENUE MIX OF THE TOP 3 PLAYERS 125

FIGURE 32 CHEETAH MEDICAL, INC.: COMPANY AT A GLANCE 126

FIGURE 33 DELTEX MEDICAL GROUP PLC: COMPANY AT A GLANCE 128

FIGURE 34 EDWARDS LIFESCIENCES CORPORATION: COMPANY AT A GLANCE 130

FIGURE 35 HEMO SAPIENS, INC.: COMPANY AT A GLANCE 133

FIGURE 36 ICU MEDICAL, INC.: COMPANY AT A GLANCE 134

FIGURE 37 LIDCO GROUP PLC: COMPANY AT A GLANCE 136

FIGURE 38 OSYPKA MEDICAL GMBH: COMPANY AT A GLANCE 139

FIGURE 39 PULSION MEDICAL SYSTEMS SE: COMPANY AT A GLANCE 141

FIGURE 40 SCHWARZER CARDIOTEK GMBH: COMPANY AT A GLANCE 143

FIGURE 41 TENSYS MEDICAL, INC.: COMPANY AT A GLANCE 145

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

41366 | MD 3211

Number of Pages

153

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Hemodynamic Monitoring System Market Research Report Forecast 2017 to 2021
The Global Hemodynamic Monitoring System Market Research Report Forecast 2017-2021 is a valuable sou...
03 May 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Flow Alteration Devices Market Research Report Forecast 2017 to 2021
The Global Hemodynamic Flow Alteration Devices Market Research Report Forecast 2017-2021 is a valua...
03 May 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring System Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Hemodynamic Monit...
02 May 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring Device Market Research Report Forecast 2017 to 2021
The Global Hemodynamic Monitoring Device Market Research Report Forecast 2017-2021 is a valuable sou...
26 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Hemodynamic Monitoring Market By Type, By End User and by Region - Industry Analysis, Size, Share, Growth Trends and Forecasts (2017 - 2022)
The global market for hemodynamic monitoring accounted for USD 931.0 million in 2016 and is expected...
01 Feb 2017 by Market Data Forecast USD $4,255 More Info
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021
The global diagnostic catheters market is projected to reach USD 4.30 billion by 2021 from USD 3.02 ...
06 Jan 2017 by MarketsandMarkets USD $5,650 More Info
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 ...
16 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 ...
16 Dec 2016 by MarketsandMarkets USD $5,650 More Info
World Interventional Cardiology & Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for ...
01 Oct 2016 by Allied Market Research USD $4,740 More Info
World Interventional Cardiology & Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for ...
01 Oct 2016 by Allied Market Research USD $5,370 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 [Published by MarketsandMarkets] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Bizwit Research and Consulting
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)
  • VPA Research